A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen Therapy to Sham Therapy in the Treatment of Diabetic Foot Ulcers

Mark Q Niederauer, Joel E Michalek, David G Armstrong, Mark Q Niederauer, Joel E Michalek, David G Armstrong

Abstract

Background: Over the past generation, preclinical data have suggested that there is a potential physiologic benefit to applying oxygen topically to wounds. However, we are unaware of any studies in the literature that have robustly assessed whether this would lead to a higher proportion of healing in similarly treated people without oxygen. Therefore, the purpose of this study was to assess this in people being treated for chronic diabetic foot ulcers (DFUs).

Methods: We enrolled and randomized 100 subjects with DFUs (79% male, aged 58.3 ± 12.1 years) to receive either active continuous diffusion of oxygen (CDO) therapy using an active CDO device, or an otherwise fully operational sham device that provided moist wound therapy (MWT) without delivering oxygen. Patients were followed until closure or 12 weeks, whichever was sooner. Patients, treating physicians and independent evaluators were blinded to the study arm. All patients received identical offloading, dressings and follow-up.

Results: There were no significant differences in assessed descriptive characteristics between the treatment arms ( P > .05 for all). A significantly higher proportion of people healed in the active arm compared to sham (46% vs 22%, P = .02). This relative effect became greater in more chronic wounds (42.5% vs 13.5%, P = .006). Patients randomized to the active device experienced significantly faster rates of closure relative to the sham ( P < .001).

Conclusions: The results of this study suggest that continuously diffused oxygen over a wound leads to significantly higher rates of closure, and faster time to closure, compared to similarly treated patients receiving standard therapy coupled with a sham device. Furthermore, the relative efficacy appears to improve the more the therapy may be needed (more chronic and larger wounds).

Keywords: closure rate; continuous diffusion of oxygen; diabetic foot ulcer; moist wound therapy; tissue oxygenation; wound healing.

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: MQN is a full-time employee of EO2 Concepts. DGA is a member of the Scientific Advisory Board of EO2 concepts.

Figures

Figure 1.
Figure 1.
Consort diagram.
Figure 2.
Figure 2.
Wound size at baseline by treatment arm and wound closure in all subjects (Active n = 50, Sham n = 50). The interaction between wound closure and wound size at baseline was not significant (P = .61). After removing the interaction term, the wound size at baseline did not vary significantly with treatment (P = .44), or wound closure (P = .11).
Figure 3.
Figure 3.
Days to wound closure by treatment arm and wound closure (%) among subjects who experienced full closure (Active n = 23, Sham n = 11). The interaction of wound closure (%) and treatment was not significant (P = .75). After removing the interaction term, the treatment effect was significant (P = .026) and the wound closure (%) effect was significant (P < .001).
Figure 4.
Figure 4.
Relative reduction in time to 50%, 75%, and full wound closure by treatment arm and wound closure among subjects who fully healed (Active n = 23, Sham n = 11).
Figure 5.
Figure 5.
Full wound closure (%) by minimum baseline wound size and treatment arm. The effect of increasing the minimum wound size at randomization is shown. For example, 2.5 cm2 indicates all wounds between 2.5 and 10.0 cm2 at randomization were included in the sample. Samples sizes are indicated in parentheses.
Figure 6.
Figure 6.
Relative performance versus minimum baseline wound size. The effect of increasing the minimum wound at randomization size is shown. For example, 2.5 cm2 indicates all wounds between 2.5 and 10.0 cm2 at randomization were included in the sample. Samples sizes are indicated in parentheses.

References

    1. Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA. Risk factors for foot infections in individuals with diabetes. Diabetes Care. 2006;29(6):1288-1293.
    1. Lavery LA, Peters EJ, Armstrong DG, Wendel CS, Murdoch DP, Lipsky BA. Risk factors for developing osteomyelitis in patients with diabetic foot wounds. Diabetes Res Clin Pract. 2009;83:347-352.
    1. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217-228.
    1. Lipsky BA, Berendt AR, Cornia PB, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54(12):e132-e173.
    1. Armstrong DG, Wrobel J, Robbins JM. Guest editorial: are diabetes-related wounds and amputations worse than cancer? Int Wound J. 2007;4(4):286-287.
    1. Morbach S, Furchert H, Groblinghoff U, et al. Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decade. Diabetes Care. 2012;35:2021-2027.
    1. Barshes NR, Sigireddi M, Wrobel JS, et al. The system of care for the diabetic foot: objectives, outcomes, and opportunities. Diabet Foot Ankle. 2013;4. doi:10.3402/dfa.v4i0.21847.
    1. Tandara AA, Mustoe TA. Oxygen in wound healing—more than a nutrient. World J Surg. 2004;28:294-300.
    1. Schreml S, Szeimies RM, Prantl L, Karrer S, Landthaler M, Bilas P. Oxygen in acute and chronic wound healing. Br J Dermatol. 2010;163:257-268.
    1. Sen CK. Wound healing essentials: let there be oxygen. Wound Rep Reg. 2009;17:1-18.
    1. Asmis R, Qiao M, Zhao Q. Low-flow oxygenation of full-excisional skin wounds on diabetic mice improves wound healing by accelerating wound closure and reepithelialization. Int Wound J. 2010;7:349-357.
    1. Pandit AS, Faldman DS. Effect of oxygen treatment and dressing oxygen permeability on wound healing. Wound Repair Regen. 1994;2:130-137.
    1. Niinikoski J. Effect of oxygen supply on wound healing and formation of experimental granulation tissue. Acta Physiol Scand. 1970;78:1-72.
    1. Hunt T, Pai M. The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis. Surg Gynecol Obstet. 1972;135:561-567.
    1. Stephens F, Hunt T. Effect of changes in inspired oxygen and carbon dioxide tensions on wound tensile strength. Ann Surg. 1971;173:515-519.
    1. Knighton DR, Silver IA, Hunt TK. Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. Surgery. 1981;90:262-270.
    1. Knighton D, Halliday B, Hunt T. Oxygen as an antibiotic: the effect of inspired oxygen on infection. Arch Surg. 1984;119:199-204.
    1. Knighton D, Halliday B, Hunt T. Oxygen as an antibiotic. Arch Surg. 1986;121:191-195.
    1. Sen CK. The general case for redox control of wound repair. Wound Repair Regen. 2003;11:431-438.
    1. Roy S, Khanna S, Sen CK. Redox regulation of the VEGF signaling path and tissue vascularization: hydrogen peroxide, the common link between physical exercise and cutaneous wound healing. Free Radic Biol Med. 2008;44:180-192.
    1. Margolis DJ, Kantor J, Santanna J, Strom BL, Berlin JA. Risk factors for delayed healing of neuropathic diabetic foot ulcers. Arch Dermatol. 2000;136:1531-1535.
    1. Urrea-Botero G. Can continuous diffusion of oxygen heal chronic toe ulcers? Podiatry Today. 2015;28(10).
    1. Brannick B, Engelthaler M, Jadzak J, Wu S. A closer look at continuous diffusion of oxygen therapy for a chronic, painful venous leg ulcer. Podiatry Today. 2014;27(11).
    1. Couture M. Does continuous diffusion of oxygen have potential in chronic diabetic foot ulcers? Podiatry Today. 2015;28(12).
    1. Driver VR, Yao M, Kantarci A, Gu G, Park N, Hasturk H. A prospective, randomized clinical study evaluating the effect of transdermal continuous oxygen therapy on biological processes and foot ulcer healing in persons with diabetes mellitus. Ostomy Wound Manage. 2013;59(11):19-26.
    1. Yu J, Lu S, McLaren A, Perry JA, Cross KM. Topical oxygen therapy results in complete wound healing in diabetic foot ulcers. Wound Rep Regen. 2016;24(6):1066-1072.
    1. Said HK, Jijjawi J, Roy N, Mogford J, Mustoe T. Transdermal sustained-delivery oxygen improves epithelial healing in a rabbit ear wound model. Arch Surg. 2005;140:998-1004.
    1. Brannick B, Engelthaler M, Jadzak J, Wu S. A closer look at continuous diffusion of oxygen therapy for a chronic, painful venous leg ulcer. Podiatry Today. 2014;27(11).
    1. Mani R. Topical oxygen therapy for chronic wounds: a report on the potential of Inotec, a new device for delivering oxygen to chronic wounds. J Wound Technol. 2010;9:1-4.
    1. Lowell DL, Nicklas B, Weeily W, Johnson F, Lyons MC. Transdermal continuous oxygen therapy as an adjunct for treatment of recalcitrant and painful wounds. Foot Ankle Online J. 2009;2(9):4.
    1. Hirsh F, Berlin SJ, Holtz A. Transdermal oxygen delivery to wounds: a report of 6 cases. Adv Skin Wound Care. 2008;22:20-24.
    1. Niederauer MQ, Michalek JE, Armstrong DG. Interim results for a prospective, randomized, double-blind multicenter study comparing continuous diffusion of oxygen therapy to standard moist wound therapy in the treatment of diabetic foot ulcers. Wound Med. 2015;8:19-23.
    1. Armstrong DG, Boulton AJM, Andros G, et al. Defining success in clinical trials of diabetic foot wounds: the Los Angeles DFCon consensus. Int Wound J. 2009;6:211-213.
    1. Sheehan P, Jones P, Giurini JM, Caselli A, Veves A. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Plast Reconstr Surg. 2006;117(suppl):239S-244S.
    1. Lavery LA, Barnes SA, Keith MS, Seaman JW, Armstrong DG. Prediction of healing for postoperative diabetic foot wounds based on early wound area progression. Diabetes Care. 2008;31:26-29.
    1. Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system: the contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care. 1998;21(5):855-859.
    1. Blume PA, Walters J, Payne W, Ayala J, Lantis J. Comparison of negative pressure wound therapy utilizing vacuum-assisted closure to advanced moist wound therapy in the treatment of diabetic foot ulcers. Diabetes Care. 2008;31(4):631-636.
    1. Armstrong DG, Marston WA, Reyzelman AM, Kirstner RS. Comparative effectiveness of mechanically and electrically powered negative pressure wound therapy devices: a multicenter randomized controlled trial. Wound Rep Regen. 2012;20(3):332-341.
    1. Marston WA, Hanft J, Norwood P, Pollak R. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers. Diabetes Care. 2003;26:1701-1705.
    1. Edmonds M. Apligraf in the treatment of neuropathic diabetic foot ulcers. Int J Low Extrem Wounds. 2009;8(1):11-18.

Source: PubMed

3
Iratkozz fel